微芯生物：向特定对象发行A股股票申请获受理

Core Points - The company received a notification from the Shanghai Stock Exchange on August 22, 2025, regarding the acceptance of its application for issuing securities for the Sci-Tech Innovation Board [1] - The company’s submitted fundraising prospectus and related application documents have been verified and accepted for review [1] - The issuance of A-shares is subject to approval from the Shanghai Stock Exchange and the China Securities Regulatory Commission, with uncertainties regarding the approval process and timeline [1] - The company will fulfill its information disclosure obligations in a timely manner [1]